OTCPicks.com’s Daily Small Cap and Microcap Newsletter presents a range of the hottest small cap stocks on trading on the OTC and OTCBB markets. In addition to our Newsletters, OTCPicks.com is quickly becoming the premier community destination for small cap and microcap traders to meet up and discuss their top stock picks. Visit http://www.otcpicks.com/ today to join this growing community.
Our Stocks to Watch today include BioSolar Inc. (OTCBB: BSRC), myPhotopipe.com Inc. (OTC: MPPC), Royal Acquisitions and Development Inc. (OTC: RQST), Immunicon Corporation (NASDAQ: IMMC), Targeted Genetics Corporation (NASDAQ: TGEN)
For the complete newsletter please visit: http://www.otcpicks.com/daily-market-movers/index.php
For more in-depth coverage of small cap stocks visit http://www.otcpicks.com/
BIOSOLAR INCORPORATED (OTC: BSRC)
Detailed Quote: http://www.otcpicks.com/quotes/BSRC.php
Company Profile: http://www.otcpicks.com/biosolar/biosolar-2.htm
BioSolar, Inc. engages in the research and development of bioplastic materials from renewable plant sources for use in photovoltaic solar cells. The company develops bio-based plastics components that meet the thermal and durability requirements of solar cell manufacturing processes for conventional crystalline cell designs, as well as thin film photovoltaic devices in an effort to capitalize on cost advantages to current petroleum based solar cell components. Its bioplastic materials can be also used directly in conventional manufacturing systems, such as injection molding and thin-film roll-to-roll, to create superstrate layer, substrate layer, and backsheet, as well as module and panel components. The company was founded in April 2006. It was formerly known as BioSolar Labs, Inc. and changed its name to BioSolar, Inc. in June 2006. BioSolar, Inc. is headquartered in Santa Clarita, California.
MYPHOTOPIPE.COM INCORPORATED (OTC: MPPC)
Detailed Quote: http://www.otcpicks.com/quotes/MPPC.php
Company Profile: http://www.otcpicks.com/myphotopipe/myphotopipe-2.htm
MyPhotopipe.com Inc. is a US-based provider of online digital photo processing and related services catering to high-end amateur and professional photographers. The Company’s primary web portal is http://www.myphotopipe.com/. Its services include photo finishing and printing, online sharing, photo books, digital photo templates, and online hosting and selling of photographs. The Company provides services to more than 18,500 professional and high-end amateur photographers nationwide; more than 190,000 copies of its software have been downloaded and are in use.
ROYAL ACQUISITIONS & DEVELOPMENT INC. (OTC: RQST)
"Up 156.25% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/RQST.php
Royal Acquisitions and Development, Inc. specializes in the development of mining, real estate and other equitable acquisitions.
IMMUNICON CORPORATION (NASD: IMMC)
"Up 12.81% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/IMMC.php
Immunicon Corporation engages in the development, manufacture, marketing, and sale of cell-based diagnostic and life science research products and service activities with a focus on cancer. The company develops technologies that identify, count, and characterize a small number of circulating tumor cells (CTC) and other rare cells present in a blood sample of a patient. It offers CellTracks AutoPrep system, an automated clinical laboratory instrument that captures, labels, and concentrates cells of interest from a sample of blood; CellSave preservative tube, a specialty blood collection device that enables to draw blood into an evacuated test tube and preserve the blood samples; and CellTracks MagNest cell presentation device for presenting magnetically labeled cells for analysis. The company also provides CellTracks Analyzer II, which is a semi-automated fluorescence microscope for rare cell analysis; and EasyCount system, a point-of-care analyzer that is designed to count specific types of cells in whole blood. In addition, it offers CellSearch circulating tumor cell kits, which are used for monitoring patients with metastatic breast cancer, metastatic colorectal cancer, and metastatic prostate cancer; CellSearch profile kit that is used to enable automated and reproducible isolation of rare cells; CellTracks circulating endothelial cell (CEC) kits and CellTracks CEC subset kits that are used for isolating and counting endothelial cells; and tumor phenotyping reagents for cell characterization. The company sells its products to hospitals, reference laboratories, oncology practices, clinical research organizations, and pharmaceutical/biotechnology companies in the United States, Canada, Europe, Japan, and other countries in Asia. It has collaboration agreements with Diagnostic Hybrids, Inc.; Kreatech Biotechnology B.V.; and University of Twente and STW. The company was founded in 1983 and is based in Huntingdon Valley, Pennsylvania.
TARGETED GENETICS CORPORATION (NASD: TGEN)
"Up 21.05% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/TGEN.php
Targeted Genetics Corporation, a clinical-stage biotechnology company, engages in the research and development of gene therapy products and technologies for the treatment of acquired and inherited diseases. It develops tgAAC94, a phase I/II clinical stage adeno-associated viral (AAV) vector product candidate for the treatment of inflammatory arthritis, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis; and tgAAC09, an AAV vector prophylactic vaccine candidate, which is under phase I and II clinical trials to protect against the progression of HIV infection to AIDS. The company also has two products in preclinical stage for the treatment of congestive heart failure and Huntington's disease. Targeted Genetics has collaboration agreements with Celladon Corporation to evaluate delivery of genes to the heart in the treatment of congestive heart failure; and with Sirna Therapeutics, Inc to develop AAV-based approaches for the treatment of Huntington's disease. The company was founded in 1989 and is based in Seattle, Washington.
About OTCPicks.com
OTCPicks.com is fast becoming the premier Internet destination for investors seeking information on smallcap and microcap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. OTCPicks.com presents the latest information for the discerning small cap and microcap investor. The site features informative articles on microcap investing, the top penny stock picks, and a wealth of small cap research on vertical markets. To feature a company on OTCPicks.com, please contact our publisher, Brian Dean at 972-546-3740, or via email at publisher@otcpicks.com.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCPicks is receiving nine thousand dollars by a third party (BlueWave Advisors) for BSRC advertising and promotion services. OTCPicks.com has been compensated four hundred thousand free trading shares from a non-controlling third party for MPPC advertising and promotional services.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.
